Other equities research analysts have also issued research reports about the stock. Piper Jaffray Cos. restated an overweight rating and issued a $127.00 target price (up previously from $95.00) on shares of Monsanto in a report on Monday, June 13th. Argus restated a buy rating and issued a $128.00 target price (up previously from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Vetr upgraded shares of Monsanto from a buy rating to a strong-buy rating and set a $122.43 target price for the company in a report on Tuesday, August 9th. Goldman Sachs Group Inc. set a $92.00 price objective on shares of Monsanto and gave the company a sell rating in a report on Monday, June 27th. Finally, JPMorgan Chase & Co. upgraded shares of Monsanto from a neutral rating to an overweight rating and set a $128.00 price objective for the company in a report on Wednesday, September 21st. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $114.65.
Shares of Monsanto (NYSE:MON) opened at 103.33 on Thursday. The stock has a market cap of $45.23 billion, a PE ratio of 34.58 and a beta of 1.19. The firm has a 50-day moving average of $104.80 and a 200-day moving average of $101.69. Monsanto has a one year low of $83.73 and a one year high of $114.26.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.19) EPS. On average, equities research analysts expect that Monsanto will post $4.89 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is 71.05%.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.88% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Third Point LLC acquired a new stake in shares of Monsanto during the second quarter valued at approximately $206,820,000. Carmignac Gestion acquired a new stake in shares of Monsanto during the second quarter valued at approximately $197,555,000. TIAA CREF Investment Management LLC boosted its stake in shares of Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its stake in shares of Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock valued at $176,327,000 after buying an additional 1,147,200 shares during the last quarter. Institutional investors and hedge funds own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.